Jane Street’s Avanos Medical AVNS Stock Holding History

Jane Street’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-100,300	Closed	-$2.85M	–	3970
2015 Q3	$2.85M	Buy	+100,300	New	+$3.5M	0.02%	735

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Jane Street's AVNS Position: Q1 2026 in Review

Jane Street increased its Avanos Medical (AVNS) stake by 932% in Q1 2026, buying an estimated $2.42M and bringing the position to 199,196 shares worth $2.79M. The position accounts for ﹤0.01% of the portfolio, ranked #4473.

Jane Street first reported a position in AVNS in Q3 2015 and has held it in 21 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

Jane Street held 199,196 shares of Avanos Medical worth $2.79M as of Q1 2026.
Jane Street bought 179,899 Avanos Medical shares in Q1 2026, an estimated $2.42M.
Avanos Medical made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4473 holding.
Jane Street first reported a position in Avanos Medical in Q3 2015 and has held it in 21 quarters since.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.